Synchrony and Reciprocity of Body Movements and Prosody Between Psychotherapist and Patient (RECiPROsody)

April 29, 2025 updated by: Giovanni Pioggia, Istituto per la Ricerca e l'Innovazione Biomedica

Study on the Synchrony and Reciprocity of Bodily Movements and Prosody Between Psychotherapist and Patient During Psychotherapy

Modern psychotherapy focuses on co-regulation, where therapist and patient interactively manage emotions. This co-regulation is seen in nonverbal communication like facial expressions, gestures, and prosody (vocal pitchs). Studies show body movements and even skin conductance synchronize between patients and therapists during sessions.

The RECiPROsody project builds on this by using technology (cameras, sensors) to record and analyze these synchronies in psychotherapy sessions. This project aims to understand how this "attunement" between therapist and patient contributes to successful therapy.

Researchers will explore how patients and therapists interact using a mobile app that records video, audio, physiological signals (heart rate), and movements. Questionnaires will assess patient well-being and therapist experience.

By studying these micro-processes, RECiPROsody hopes to gain insights into how the therapeutic relationship develops, including the connections between physical reactions, nonverbal communication, and overall progress. This knowledge can improve psychotherapeutic techniques and highlight the importance of the nonverbal communication in therapy.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Messina, Italy, 98164
        • Recruiting
        • Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR)
        • Sub-Investigator:
          • Gennaro Tartarisco
        • Contact:
        • Sub-Investigator:
          • Serena Iacono Isidoro
        • Sub-Investigator:
          • Gaspare Cusimano
        • Principal Investigator:
          • Giovanni Pioggia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

All patients admitted to the HCC Italy Clinical and Psychotherapy Research Center and who meet the inclusion and exclusion criteria will be enrolled, after signing informed consent

Description

Inclusion Criteria:

  • Male and female adults between the ages of 20 and 60 years old who are referred to the HCC Italy Clinical and Psychotherapy Research Center

Exclusion Criteria:

  • Patients under 20 years of age
  • Presence of paranoid or psychotic symptoms
  • Admissions to psychiatric Operative Units that have occurred within the last year since the start of psychotherapy at the HCC Italy Clinical and Psychotherapy Research Center

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Subjects starting psychotherapy at the HCC Italy Clinical and Psychotherapy Research Center
The population that decides to undertake psychotherapy is diverse, including individuals of various ages, genders, socioeconomic backgrounds, and occupations. Motivations can vary widely, but often include management of mental disorders, relationship problems, stress, and personal growth. Despite existing barriers, a growing number of people are recognizing the importance of mental well-being and seeking professional support: increasing awareness and reduced stigma related to psychological symptoms are making psychotherapy an increasingly considered option for improving mental well-being and quality of life.
Gestalt psychotherapy is an aesthetic-phenomenological approach that aims to improve self-awareness and integration by promoting emotional and relational well-being through what is happening in the present moment in the relationship with the therapist. The patient's current experiences are explored to better understand problems and behaviors and by promoting relational self-regulation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Outcomes in Routine Evaluation Outcome Measure (CORE-OM)
Time Frame: The questionnaire will be administered to patients pre-intervention, before the start of psychotherapy [T0] and 6 months after the start of psychotherapy [T1].

CORE-OM is a 34-item self-administered questionnaire useful for assessing the outcome of psychological interventions. The CORE items relate to four domains: subjective well-being (4 items), symptoms/problems (12 items), functioning (12 items), and risk (6 items). Use of the CORE-OM provides useful insights by facilitating understanding of the patient's progress during the psychotherapeutic process. Each item is scored on a 5-point scale ranging from 0 (not at all) to 4 (most or all the time).

The total score is calculated by adding the response values of all 34 items. The minimum score that can be achieved is 0 and the maximum 136, with higher scores indicating higher distress. Severity consists of six categories, characterizing respondents' psychological distress as either healthy (a score < 6), low-level (6-9), mild (10-14), moderate (15-19), moderate-severe (20-24) or severe (a score > 24).

The questionnaire will be administered to patients pre-intervention, before the start of psychotherapy [T0] and 6 months after the start of psychotherapy [T1].
Therapist Response Questionnaire (TRQ)
Time Frame: The questionnaire will be filled out by psychotherapists after the first 4 psychotherapy sessions and every 4 sessions.

The TRQ is a clinician report of 79 items that measure a wide spectrum of thoughts, feelings, and behaviors expressed by therapists toward their patients, ranging from relatively specific feelings (e.g., "I feel bored in sessions with him/her") to complex constructs, such as projective identification (e.g., "More than with most patients, I feel like I've been pulled into things that I didn't realize until after the session was over").

Items are derived by reviewing the clinical, theoretical, and empirical literature on countertransference and related variables, so that the instrument could be used comparably by therapists of any orientation. The clinicians assess each item on a 5-point Likert scale, ranging from 1 (not true) to 5 (very true). A total TRQ score was calculated by summing all 79 variables. The minimum score that can be achieved is 79 and the maximum 395. This TRQ total score was supposed to capture the general level of self-reported countertransference.

The questionnaire will be filled out by psychotherapists after the first 4 psychotherapy sessions and every 4 sessions.
Aesthetic Relational Knowing of the Therapist (ARK-T)
Time Frame: The questionnaire will be filled out by psychotherapists after the first 4 psychotherapy sessions.
The ARK-T scale is a 21-items measure of the therapist's aesthetic and field intuition during the psychotherapeutic process. It is composed by three main factors, "Bodily Awareness" (8 items), "Intuitive Resonance" (8 items), "Affective Empathy" (5 items). Each item is scored on a 5-point scale ranging from 1 (strongly disagree) to 5 (strongly agree). The score could range from 21 to 105 and it could be correlate with the outcome of psychotherapy, or even with the measurement of relational factors such as the therapist's responsiveness, his or her self-compassion, and many other aspects developed within the various psychotherapeutic approaches. It will thus be possible to correlate this particular type of insight, to date little studied in the literature, with the effectiveness of psychotherapy, as well as with other aspects of the therapist's training and personality, e.g., personal psychotherapy, caring attitude toward self, ethics of responsivity toward the patient.
The questionnaire will be filled out by psychotherapists after the first 4 psychotherapy sessions.
Clinical Outcomes in Routine Evaluation - Assessment (CORE-A)
Time Frame: The instrument will be filled out by the therapist after the first 4 sessions.
The CORE-A allows for the collection of demographic data regarding patient, referral (date, first episode, relapse), patient's resources (family, financial condition), previous or ongoing treatment to ongoing drug treatments, on the severity of the disorder (4-point scale) and its duration (<6 months, 6-12 months, >12 months, recurrent), data on self- and heterolesive risk (4-point scale), on the outcome of the assessment (accepted psychotherapy, sent, etc.)
The instrument will be filled out by the therapist after the first 4 sessions.
Clinical Outcomes in Routine Evaluation - End of therapy (CORE-E)
Time Frame: The instrument will be filled out by the therapist 6 months after the start of psychotherapy [T1].
The CORE-E, also filled out by the therapist, collects data (comparable with the Assessment) on the type of psychotherapy performed, modality, frequency, mode of termination, reassessment of problems assessed at assessment and risk, assessment of contextual factors (motivation, therapeutic alliance, level of mentalization), benefits of therapy (e.g, insight capacity, expression of problems and moods, coping strategies, ability to make decisions, to ask for help, subjective well-being, symptoms, daily functioning, interpersonal relationships, possible drug therapy, and to agreements on possible follow-up).
The instrument will be filled out by the therapist 6 months after the start of psychotherapy [T1].

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Giovanni Pioggia, Istituto per la Ricerca e l'Innovazione Biomedica

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Gallese, V. (2009). Mirror neurons, embodied simulation, and the neural basis of social identification. Psychoanalytic Dialogues, 19(5), 519-536. https://doi.org/10.1080/10481880903231910
  • Reinecke K.C.H., Dvoretska1 D., Joraschky P., Lausberg H. (2020). Fidgeting Behavior During Psychotherapy: Hand Movement Structure Contains Information About Depressive Symptoms. Journal of Contemporary Psychotherapy, 50:323-329 doi: 10.1007/s10879-020-09465-5
  • Schore J., Schore A. (2008). Modern attachment theory: the central role of affect regulation in development and treatment. Clin. Soc. Work J. 36: 9-20. doi: 10.1007/s10615-007-0111-7
  • Tschacher W, Meier D. Physiological synchrony in psychotherapy sessions. Psychother Res. 2020 Jun;30(5):558-573. doi: 10.1080/10503307.2019.1612114. Epub 2019 May 6.
  • Wampold, B.E., Imel, Z. E. (2015). The Great Psychotherapy Debate: The Evidence for What Makes Psychotherapy Work. Abingdom: Routledge.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2024

Primary Completion (Estimated)

April 30, 2026

Study Completion (Estimated)

September 30, 2026

Study Registration Dates

First Submitted

June 11, 2024

First Submitted That Met QC Criteria

June 14, 2024

First Posted (Actual)

June 18, 2024

Study Record Updates

Last Update Posted (Actual)

May 1, 2025

Last Update Submitted That Met QC Criteria

April 29, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • CNR-IRIB-PRO-2024-006

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Relationship, Professional Patient

Clinical Trials on Psychotherapy - Gestalt psychotherapy

Subscribe